Advances in the diagnosis and management of pediatric osteomyelitis

Current Infectious Disease Reports

Volumn 13, Issue 5, 2011, Pages 451-460

  Thomsen, Isaac ^a,b   Creech, C Buddy ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Children; Community associated MRSA; Kingella kingae; Osteomyelitis

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CEFALEXIN; CEFAZOLIN; CEFTAROLINE; CEFTOBIPROLE; CEPHALOSPORIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DAPTOMYCIN; LINEZOLID; NAFCILLIN; OXACILLIN; RIFAMPICIN; TEFIBAZUMAB; VANCOMYCIN;

ACUTE DISEASE; ADJUVANT CHEMOTHERAPY; ANEMIA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL SKIN DISEASE; CHILD HEALTH CARE; CLINICAL FEATURE; COMMUNICABLE DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CULTURE TECHNIQUE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG CHOICE; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; DRUG SAFETY; ENTEROCOCCAL INFECTION; ERYTHROCYTE SEDIMENTATION RATE; EVIDENCE BASED MEDICINE; HEMATOGENOUS OSTEOMYELITIS; HUMAN; KINGELLA KINGAE; LIVER TOXICITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIPLEX POLYMERASE CHAIN REACTION; NEISSERIACEAE INFECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; REPEAT PROCEDURE; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT PLANNING;

EID: 80052560137     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-011-0202-z     Document Type: Article

References (77)

1. Krogstad P. Osteomyelitis. In: Feigin RD, Cherry JD, Kaplan SL, Demmler-Harrison GJ, editors. Feigin and Cherry's textbook of pediatric infectious diseases. Philadelphia: Saunders Elsevier; 2009.
2. Fleisher GR, Ludwig S. Textbook of pediatric emergency medicine. 6th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010. xxx, 1970 p.
3. M Vazquez 2002 Osteomyelitis in children Curr Opin Pediatr 14 1 112 115 11880745 10.1097/00008480-200202000-00020 (Pubitemid 34169580)
4. Long SS, Pickering LK, Prober CG. Principles and practice of pediatric infectious diseases. 3rd rev. ed. Philadelphia: Churchill Livingstone/Elsevier; 2008. xxxiii, 1618 p.
5. JB Chambers DA Forsythe SL Bertrand, et al. 2000 Retrospective review of osteoarticular infections in a pediatric sickle cell age group J Pediatr Orthop 20 5 682 685 11008753 10.1097/01241398-200009000-00025 1:STN:280: DC%2BD3cvlt1eksA%3D%3D
6. SL Kaplan 2009 Challenges in the evaluation and management of bone and joint infections and the role of new antibiotics for gram positive infections Adv Exp Med Biol 634 111 120 19280853
7. PS Pannaraj KG Hulten BE Gonzalez, et al. 2006 Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection Clin Infect Dis 43 8 953 960 16983604 10.1086/507637 (Pubitemid 44631092)
8. SR Arnold D Elias SC Buckingham, et al. 2006 Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus J Pediatr Orthop 26 6 703 708 17065930 10.1097/01.bpo.0000242431.91489.b4 (Pubitemid 44655534)
9. JJ Hawkshead NB Patel RW Steele SD Heinrich 2009 Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus J Pediatr Orthop 29 1 85 90 19098653 10.1097/BPO.0b013e3181901c3a This retrospective study of 97 children with staphylococcal osteomyelitis suggests that MRSA osteomyelitis is more severe and requires more aggressive surgical and medical management
10. Williams DJ, Deis JN, Tardy J, Creech CB. Culture-negative osteoarticular infections in the era of community-associated methicillin-resistant staphylococcus aureus. Pediatr Infect Dis J. 2011;30(6):523-25. This study showed that while culture-negative osteoarticular infections are milder compared with culture-positive infections, the duration of parenteral antibiotics for these infections has increased dramatically in recent years.
11. CE Bocchini KG Hulten EO Mason, et al. 2006 Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children Pediatrics 117 2 433 440 16452363 10.1542/peds.2005-0566 (Pubitemid 46071606)
12. K Moumile C Cadilhac G Lina, et al. 2006 Severe osteoarticular infection associated with Panton-Valentine leukocidin-producing Staphylococcus aureus Diagn Microbiol Infect Dis 56 1 95 97 16678376 10.1016/j.diagmicrobio.2006.03. 007 (Pubitemid 44279943)
13. JM Voyich M Otto B Mathema, et al. 2006 Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194 12 1761 1770 17109350 10.1086/509506 1:CAS:528:DC%2BD2sXhvVKltw%3D%3D (Pubitemid 44902009)
14. A Cunnington T Brick M Cooper, et al. 2009 Severe invasive Panton-Valentine Leucocidin positive Staphylococcus aureus infections in children in London, UK J Infect 59 1 28 36 19560210 10.1016/j.jinf.2009.05.003 1:STN:280:DC%2BD1MvotFemsQ%3D%3D
15. KL Vander Have B Karmazyn M Verma, et al. 2009 Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a game changer J Pediatr Orthop 29 8 927 931 19934711 10.1097/BPO.0b013e3181bd1e0c
16. Von Graevenitz AZR, Mutters R. Actinobacillus, Capnocytophaga, Eikenella, Kingella, Pasteurella, and other fastidious or rarely encountered gram-negative rods. In: Baron EJ, Murray PR, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology. Washington: American Society for Microbiology; 2003. p. 614-5.
17. P Yagupsky N Porat E Pinco 2009 Pharyngeal colonization by Kingella kingae in children with invasive disease Pediatr Infect Dis J 28 2 155 157 19106774 10.1097/INF.0b013e318184dbb8
18. P Yagupsky 2004 Kingella kingae: from medical rarity to an emerging paediatric pathogen Lancet Infect Dis 4 6 358 367 15172344 10.1016/S1473- 3099(04)01046-1 (Pubitemid 38692700)
19. G Dubnov-Raz M Ephros B-Z Garty, et al. 2010 Invasive pediatric Kingella kingae infections: a nationwide collaborative study Pediatr Infect Dis J 29 7 639 643 20182400 10.1097/INF.0b013e3181d57a6c This large study helped to define Kingella as an important pathogen in children age 6 to 36 months
20. P Yagupsky E Porsch JW St. Geme 3rd 2011 Kingella kingae: an emerging pathogen in young children Pediatrics 127 3 557 21321033 10.1542/peds.2010-1867 These authors provide an excellent revew of Kingella kingae, including its importance as an etiology of osteomyelitis in young children
21. P Yagupsky R Dagan F Prajgrod M Merires 1995 Respiratory carriage of Kingella kingae among healthy children Pediatr Infect Dis J 14 8 673 678 8532424 10.1097/00006454-199508000-00005 1:STN:280:DyaK28%2Fhs1CgsA%3D%3D
22. P Yagupsky M Merires J Bahar R Dagan 1995 Evaluation of novel vancomycin-containing medium for primary isolation of Kingella kingae from upper respiratory tract specimens J Clin Microbiol 33 5 1426 1427 7615773 1:STN:280:DyaK2MzktVyjsA%3D%3D
23. P Yagupsky I Weiss-Salz R Fluss, et al. 2009 Dissemination of Kingella kingae in the community and long-term persistence of invasive clones Pediatr Infect Dis J 28 8 707 710 19593253 10.1097/INF.0b013e31819f1f36
24. S Chometon Y Benito M Chaker, et al. 2007 Specific real-time polymerase chain reaction places Kingella kingae as the most common cause of osteoarticular infections in young children Pediatr Infect Dis J 26 5 377 381 17468645 10.1097/01.inf.0000259954.88139.f4 (Pubitemid 46789316)
25. M Pääkkönen MJT Kallio PE Kallio H Peltola 2010 Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections Clin Orthop Relat Res 468 3 861 866 19533263 10.1007/s11999-009-0936-1 This study examined the use of both ESR and CRP for initial diagnosis and monitoring of pediatric osteoarticular infection, finding that the combination of both tests maximizes the sensitivity, and demonstrating that CRP normalizes much more quickly
26. L Unkila-Kallio MJ Kallio J Eskola H Peltola 1994 Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children Pediatrics 93 1 59 62 8265325 1:STN:280:DyaK2c%2FovFemtA%3D%3D (Pubitemid 24012130)
27. AG Khachatourians MJ Patzakis N Roidis PD Holtom 2003 Laboratory monitoring in pediatric acute osteomyelitis and septic arthritis Clin Orthop Relat Res 409 186 194 12671501 10.1097/01.blo.0000057991.41099.47 (Pubitemid 36417728)
28. I Roine I Faingezicht A Arguedas, et al. 1995 Serial serum C-reactive protein to monitor recovery from acute hematogenous osteomyelitis in children Pediatr Infect Dis J 14 1 40 44 7715988 10.1097/00006454-199501000-00008 1:STN:280:DyaK2M3jtF2gsw%3D%3D
29. M Ranson 2009 Imaging of pediatric musculoskeletal infection Semin Musculoskelet Radiol 13 3 277 299 19724994 10.1055/s-0029-1237693 This is an excellent review of imaging modalities for pediatric bone and joint infections
30. LP Browne EO Mason SL Kaplan, et al. 2008 Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children Pediatr Radiol 38 8 841 847 18560822 10.1007/s00247-008-0888-8
31. RK Lalam VN Cassar-Pullicino BJ Tins 2007 Magnetic resonance imaging of appendicular musculoskeletal infection Top Magn Reson Imag 18 3 177 191 10.1097/RMR.0b0318123eee56 (Pubitemid 47357420)
32. D Jaramillo ST Treves JR Kasser, et al. 1995 Osteomyelitis and septic arthritis in children: appropriate use of imaging to guide treatment AJR Am J Roentgenol 165 2 399 403 7618566 1:STN:280:DyaK2Mzktlymug%3D%3D
33. JM Mazur G Ross J Cummings, et al. 1995 Usefulness of magnetic resonance imaging for the diagnosis of acute musculoskeletal infections in children J Pediatr Orthop 15 2 144 147 7745082 1:STN:280:DyaK2M3mtlOquw%3D%3D
34. SA Connolly LP Connolly LA Drubach, et al. 2007 MRI for detection of abscess in acute osteomyelitis of the pelvis in children AJR Am J Roentgenol 189 4 867 872 17885058 10.2214/AJR.07.2416 (Pubitemid 47479769)
35. PM Courtney JM Flynn D Jaramillo, et al. 2010 Clinical indications for repeat MRI in children with acute hematogenous osteomyelitis J Pediatr Orthop 30 8 883 887 21102217 10.1097/BPO.0b013e3181fcbae5 This study found that a repeat MRI did not have a useful role in the routine management of pediatric AHO, though it may be helpful in patients who are not improving on standard therapy
36. K Moumile J Merckx C Glorion, et al. 2003 Osteoarticular infections caused by Kingella kingae in children: contribution of polymerase chain reaction to the microbiologic diagnosis Pediatr Infect Dis J 22 9 837 839 14515832 (Pubitemid 37153084)
37. I Verdier A Gayet-Ageron C Ploton, et al. 2005 Contribution of a broad range polymerase chain reaction to the diagnosis of osteoarticular infections caused by Kingella kingae: description of twenty-four recent pediatric diagnoses Pediatr Infect Dis J 24 8 692 696 16094222 10.1097/01.inf.0000172153.10569.dc (Pubitemid 41140951)
38. B Ilharreborde P Bidet M Lorrot, et al. 2009 New real-time PCR-based method for Kingella kingae DNA detection: application to samples collected from 89 children with acute arthritis J Clin Microbiol 47 6 1837 1841 19369442 10.1128/JCM.00144-09 1:CAS:528:DC%2BD1MXosVeisb0%3D
39. AL Rosey E Abachin G Quesnes, et al. 2007 Development of a broad-range 16S rDNA real-time PCR for the diagnosis of septic arthritis in children J Microbiol Meth 68 1 88 93 10.1016/j.mimet.2006.06.010 1:CAS:528: DC%2BD2sXkvF2gsA%3D%3D (Pubitemid 46054322)
40. F Fenollar P-Y Lévy D Raoult 2008 Usefulness of broad-range PCR for the diagnosis of osteoarticular infections Curr Opin Rheumatol 20 4 463 470 18525362 10.1097/BOR.0b013e3283032030 1:CAS:528:DC%2BD1cXms1yntLc%3D
41. F Fenollar V Roux A Stein, et al. 2006 Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections J Clin Microbiol 44 3 1018 1028 16517890 10.1128/JCM.44.3.1018-1028.2006 1:CAS:528:DC%2BD28XjsVylurY%3D
42. Fihman V, Hannouche D, Bousson V, et al. Improved diagnosis specificity in bone and joint infections using molecular techniques. J Infect. 2007;55(6):510-17. (Pubitemid 350089281)
43. D Stengel K Bauwens J Sehouli, et al. 2001 Systematic review and meta-analysis of antibiotic therapy for bone and joint infections Lancet Infect Dis 1 3 175 188 11871494 10.1016/S1473-3099(01)00094-9 1:CAS:528: DC%2BD38XltVOntr4%3D (Pubitemid 33586051)
44. SL Kaplan 2005 Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients Infect Dis Clin North Am 19 3 747 757 16102659 10.1016/j.idc.2005.05.011 (Pubitemid 41133539)
45. MZ David RS Daum 2010 Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic Clin Microbiol Rev 23 3 616 687 20610826 10.1128/CMR.00081-09 1:CAS:528:DC%2BC3cXhtFWgtLnN
46. JC Herigon AL Hersh JS Gerber, et al. 2010 Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008 Pediatrics 125 6 e1294 e1300 20478934 10.1542/peds.2009-2867 This paper examined antibiotic prescribing patterns over the last decade, finding that clindamycin is now the most common antibiotic prescribed for S. aureus infections in children, including osteomyelitis
47. G Sakoulas PA Moise-Broder J Schentag, et al. 2004 Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J Clin Microbiol 42 6 2398 2402 15184410 10.1128/JCM.42.6.2398-2402.2004 1:CAS:528: DC%2BD2cXlslamtLY%3D (Pubitemid 38747480)
48. L Braun D Craft R Williams, et al. 2005 Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities Pediatr Infect Dis J 24 7 622 626 15999004 10.1097/01.inf.0000171175.76673.64 (Pubitemid 40993617)
49. S Chavez-Bueno B Bozdogan K Katz, et al. 2005 Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas Antimicrob Agents Chemother 49 6 2283 2288 15917522 10.1128/AAC.49.6.2283-2288.2005 1:CAS:528:DC%2BD2MXkvFCgsr4%3D (Pubitemid 40734455)
50. LL Han LK McDougal RJ Gorwitz, et al. 2007 High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center J Clin Microbiol 45 4 1350 1352 17287335 10.1128/JCM.02274-06 1:CAS:528:DC%2BD2sXlt1Oisrw%3D (Pubitemid 46626515)
51. KM McMullen DK Warren KF Woeltje 2009 The changing susceptibilities of methicillin-resistant Staphylococcus aureus at a midwestern hospital: the emergence of "community-associated" MRSA Am J Infect Control 37 6 454 457 19118922 10.1016/j.ajic.2008.09.015
52. G Martinez-Aguilar WA Hammerman EO Mason Jr SL Kaplan 2003 Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children Pediatr Infect Dis J 22 7 593 598 12867833 (Pubitemid 36900204)
53. SA Grim RP Rapp CA Martin ME Evans 2005 Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus Pharmacotherapy 25 2 253 264 15767239 10.1592/phco.25.2. 253.56956 1:CAS:528:DC%2BD2MXhvFyks7s%3D (Pubitemid 40223485)
54. G Euba O Murillo N Fernandez-Sabe, et al. 2009 Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis Antimicrob Agents Chemother 53 6 2672 2676 19307354 10.1128/AAC.01504-08 1:CAS:528:DC%2BD1MXntFGksbo%3D
55. C Liu A Bayer SE Cosgrove, et al. 2011 Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children Clin Infect Dis 52 3 e18 e55 21208910 10.1093/cid/ciq146 These recently-released guidelines from the Infectious Diseases Society of America include detailed recommendations on the treatment of MRSA osteomyelitis in children
56. WE Rose PT Poppens 2009 Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus J Antimicrob Chemother 63 3 485 488 19109338 10.1093/jac/dkn513 1:CAS:528:DC%2BD1MXitVSitLg%3D
57. DP Levine BS Fromm BR Reddy 1991 Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis Ann Intern Med 115 9 674 680 1929035 1:STN:280: DyaK38%2FislantQ%3D%3D
58. S Deresinski 2009 Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections Clin Infect Dis 49 7 1072 1079 19725789 10.1086/605572 1:CAS:528: DC%2BD1MXhtlehs7rN
59. J Dotis E Iosifidis M Ioannidou E Roilides 2010 Use of linezolid in pediatrics: a critical review Int J Infect Dis 14 8 e638 e648 20106697 10.1016/j.ijid.2009.10.002 1:CAS:528:DC%2BC3MXmtVCi This is a thorough review of the safety and efficacy of linezolid for a variety of infections in children, including osteomyelitis
60. C-J Chen C-H Chiu T-Y Lin, et al. 2007 Experience with linezolid therapy in children with osteoarticular infections Pediatr Infect Dis J 26 11 985 988 17984803 10.1097/INF.0b013e31812e62dc (Pubitemid 350287578)
61. DAK Rice L Mendez-Vigo 2009 Daptomycin in bone and joint infections: a review of the literature Arch Orthop Trauma Surg 129 11 1495 1504 18989686 10.1007/s00402-008-0772-x
62. M Lefebvre C Jacqueline G Amador, et al. 2010 Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis Int J Antimicrob Agents 36 6 542 544 20851576 10.1016/j.ijantimicag.2010.07.008 1:CAS:528:DC%2BC3cXhsVagur3O
63. A Villegas-Estrada M Lee D Hesek, et al. 2008 Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics J Am Chem Soc 130 29 9212 9213 18582062 10.1021/ja8029448 1:CAS:528:DC%2BD1cXnvF2gu7c%3D (Pubitemid 352031115)
64. GM Eliopoulos 2009 Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria J Infect 59 Suppl 1 S17 S24 19766885 10.1016/S0163-4453(09)60004-9
65. JB Laudano 2011 Ceftaroline fosamil: a new broad-spectrum cephalosporin J Antimicrob Chemother 66 Suppl 3 iii11 iii18 21482565 10.1093/jac/dkr095 1:CAS:528:DC%2BC3MXkvFahsrg%3D
66. ClinicalTrials.gov NIoH. Study of blood levels of ceftaroline fosamil in children who are receiving antibiotic therapy in the hospital. [cited Accessed May 2011. Available from: http://clinicaltrials.gov/ct2/show/NCT01298843 ].
67. C Jacqueline G Amador J Caillon, et al. 2010 Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis J Antimicrob Chemother 65 8 1749 1752 20530506 10.1093/jac/dkq193 1:CAS:528:DC%2BC3cXptVyqsbY%3D This paper describes the use of ceftaroline, a new 5th-generation cephalosporin with MRSA activity, in an animal model of osteomyelitis
68. D McDevitt P Francois P Vaudaux TJ Foster 1994 Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus Mol Microbiol 11 2 237 248 8170386 10.1111/j.1365-2958.1994.tb00304.x 1:CAS:528:DyaK2cXitFSqu7w%3D (Pubitemid 24201596)
69. E Josefsson O Hartford L O'Brien, et al. 2001 Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant J Infect Dis 184 12 1572 1580 11740733 10.1086/324430 1:CAS:528:DC%2BD38XjvVaqsQ%3D%3D (Pubitemid 33139743)
70. JJ Weems Jr JP Steinberg S Filler, et al. 2006 Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia Antimicrob Agents Chemother 50 8 2751 2755 16870768 10.1128/AAC.00096-06 1:CAS:528:DC%2BD28Xotlehsbo%3D (Pubitemid 44198697)
71. PJ Domanski PR Patel AS Bayer, et al. 2005 Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus Infect Immun 73 8 5229 5232 16041045 10.1128/IAI.73.8. 5229-5232.2005 1:CAS:528:DC%2BD2MXmvVCitrY%3D (Pubitemid 41105686)
72. T Zaoutis AR Localio K Leckerman, et al. 2009 Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children Pediatrics 123 2 636 642 19171632 10.1542/peds.2008- 0596 This large retrospective cohort study clearly showed that an early transition to oral antimicrobial therapy avoided the risk of prolonged parenteral therapy without increasing the risk of treatment failure
73. H Peltola L Unkila-Kallio MJ Kallio 1997 Simplified treatment of acute staphylococcal osteomyelitis of childhood. The Finnish Study Group Pediatrics 99 6 846 850 9190554 10.1542/peds.99.6.846 1:STN:280:DyaK2szjtVKisQ%3D%3D (Pubitemid 27231358)
74. N Le Saux A Howard NJ Barrowman, et al. 2002 Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review BMC Infect Dis 2 16 12181082 10.1186/1471-2334-2-16 (Pubitemid 38750900)
75. Barrier A, Connelly M, Williams D, et al. Complications of peripherally-inserted central catheters for antibiotic administration. In: Pediatric hospital medicine conference. 2010. Minneapolis, MN.
76. S Weichert M Sharland NM Clarke SN Faust 2008 Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat? Curr Opin Infect Dis 21 3 258 262 18448970 10.1097/QCO.0b013e3283005441 (Pubitemid 351620380)
77. H Peltola M Pääkkönen P Kallio, et al. 2010 Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases Pediatr Infect Dis J 29 12 1123 1128 20842069 10.1097/INF.0b013e3181f55a89 This randomized trial found that a 20-day course of antibiotic therapy, with only a short period administered parenterally, was as effective as longer courses. However, this may not be directly applicable to populations with high rates of CA-MRSA, which was not a pathogen in this study